Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

636 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of the efficacy and safety of tavaborole topical solution, 5%, in the treatment of onychomycosis of the toenail in adults: a pooled analysis of an 8-week, post-study follow-up from two randomized phase 3 studies.
Gupta AK, Hall S, Zane LT, Lipner SR, Rich P. Gupta AK, et al. Among authors: rich p. J Dermatolog Treat. 2018 Feb;29(1):44-48. doi: 10.1080/09546634.2017.1329510. Epub 2017 May 30. J Dermatolog Treat. 2018. PMID: 28521541 Clinical Trial.
Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail.
Scher RK, Breneman D, Rich P, Savin RC, Feingold DS, Konnikov N, Shupack JL, Pinnell S, Levine N, Lowe NJ, Aly R, Odom RB, Greer DL, Morman MR, Bucko AD, Tschen EH, Elewski BE, Smith EB. Scher RK, et al. Among authors: rich p. J Am Acad Dermatol. 1998 Jun;38(6 Pt 2):S77-86. doi: 10.1016/s0190-9622(98)70490-6. J Am Acad Dermatol. 1998. PMID: 9631989 Clinical Trial.
Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail.
Rich P, Scher RK, Breneman D, Savin RC, Feingold DS, Konnikov N, Shupack JL, Pinnell S, Levine N, Lowe NJ, Aly R, Odom RB, Greer DL, Morman MR, Bucko AD, Tschen EH, Elewski BE, Smith EB, Hilbert J. Rich P, et al. J Am Acad Dermatol. 1998 Jun;38(6 Pt 2):S103-9. doi: 10.1016/s0190-9622(98)70493-1. J Am Acad Dermatol. 1998. PMID: 9631992 Clinical Trial.
Fluconazole for the treatment of onychomycosis: an update.
Gupta AK, Scher RK, Rich P. Gupta AK, et al. Among authors: rich p. Int J Dermatol. 1998 Nov;37(11):815-20. doi: 10.1046/j.1365-4632.1998.00564.x. Int J Dermatol. 1998. PMID: 9865864 Review. No abstract available.
A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns.
Ghannoum MA, Hajjeh RA, Scher R, Konnikov N, Gupta AK, Summerbell R, Sullivan S, Daniel R, Krusinski P, Fleckman P, Rich P, Odom R, Aly R, Pariser D, Zaiac M, Rebell G, Lesher J, Gerlach B, Ponce-De-Leon GF, Ghannoum A, Warner J, Isham N, Elewski B. Ghannoum MA, et al. Among authors: rich p. J Am Acad Dermatol. 2000 Oct;43(4):641-8. doi: 10.1067/mjd.2000.107754. J Am Acad Dermatol. 2000. PMID: 11004620
Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs.
Elewski BE, Ghannoum MA, Mayser P, Gupta AK, Korting HC, Shouey RJ, Baker DR, Rich PA, Ling M, Hugot S, Damaj B, Nyirady J, Thangavelu K, Notter M, Parneix-Spake A, Sigurgeirsson B. Elewski BE, et al. Among authors: rich pa. J Eur Acad Dermatol Venereol. 2013 Mar;27(3):287-94. doi: 10.1111/j.1468-3083.2011.04373.x. Epub 2011 Dec 20. J Eur Acad Dermatol Venereol. 2013. PMID: 22181693
636 results